Skip to content
PubMed This is a summary of 7 peer-reviewed journal articles Updated
Neurology

Is Multifocal Motor Neuropathy (MMN) Hereditary or Genetic?

At a Glance

Multifocal motor neuropathy (MMN) is an acquired autoimmune condition, not an inherited disease, so it does not usually pass predictably from parent to child. Genetic counseling may be useful when symptoms start unusually early or several relatives have similar weakness.

It is completely understandable to worry about whether your diagnosis could affect your children.

The Bottom Line: Multifocal motor neuropathy (MMN) is an acquired autoimmune condition, not an inherited genetic disease [1]. There is no established, predictable pattern of passing MMN from parent to child [1]. Routine predictive genetic testing for MMN is not recommended for children of a parent with MMN.

Why MMN is Considered “Acquired”

In medicine, an acquired condition is one that develops over the course of your life, rather than being determined by your genes at birth. MMN occurs when your immune system mistakenly attacks your own peripheral nerves—the nerves outside your brain and spinal cord, specifically those controlling muscle movement [1].

The exact cause of this immune response isn’t fully understood, but it is not passed down through families [1]. In some people with MMN, the immune system produces anti-GM1 antibodies. These antibodies can target motor nerves, though they are only present in a subset of patients [2][3]. A negative anti-GM1 test does not mean you don’t have MMN, and a positive result helps support the diagnosis but doesn’t prove it on its own [3].

Because MMN is driven by the immune system, treatments like intravenous immunoglobulin (IVIG)—a therapy that helps calm an overactive immune system—are often effective at maintaining or improving muscle strength [3][1]. However, responding well to IVIG is not a substitute for a thorough diagnosis, and it may not reverse long-standing muscle weakness [1].

What About Genetic Susceptibility?

While MMN itself is not a hereditary disease, researchers have identified certain genetic factors that might slightly increase a person’s susceptibility to developing the condition. For example, specific variations in genes related to the immune system (such as HLA genes or the CD55 gene) have been observed as research associations in some people with MMN [4][5].

Having a genetic susceptibility is very different from having an inherited disease. These genetic variations might subtly influence how your immune system behaves, but they do not cause the disease on their own and are not inherited in a predictable familial pattern [4][5].

When to Consider Other Explanations

Because MMN shares symptoms with other nerve and muscle disorders, it is important to ensure your diagnosis is accurate. MMN typically involves adult-onset, slowly progressive, asymmetric weakness (often in the hands or arms) without significant sensory loss [1].

There is a different group of diseases known as hereditary motor neuropathies [6][7]. Unlike MMN, these conditions are genetic. While they often run in families, they can sometimes appear without a known family history due to new (de novo) genetic changes or recessive inheritance patterns [6].

Your neurologist will use your clinical history and electrodiagnostic testing (which includes nerve conduction studies and needle EMG) to tell these conditions apart. They often look for conduction block—a partial interruption of the electrical signal along a nerve [1]. While conduction block can support an MMN diagnosis, it must be carefully interpreted alongside your overall clinical picture, as it is not exclusive to MMN [1].

If several members of your family have experienced similar progressive muscle weakness, or if your symptoms began unusually early in life, it is worth discussing these details with your doctor or a genetic counselor to confirm the diagnosis [6][7].

Common questions in this guide

Can multifocal motor neuropathy be passed from a parent to a child?
Multifocal motor neuropathy is an acquired autoimmune condition rather than an inherited disease. There is no established, predictable pattern for passing it from parent to child, so routine predictive genetic testing is not generally recommended for children of a parent with MMN.
Can genes increase a person's chance of developing MMN?
Some immune-related gene variations, including changes involving HLA or CD55, have been associated with MMN in research. These variations may affect immune-system susceptibility, but they do not cause MMN by themselves or create a predictable family inheritance pattern.
How is MMN different from a hereditary motor neuropathy?
MMN usually begins in adulthood and causes slowly progressive, uneven weakness, often in the hands or arms, with little sensory loss. A neurologist uses the symptom history, nerve conduction studies, and needle EMG to distinguish MMN from genetic motor neuropathies, which may run in families or arise from new genetic changes.
When should someone with MMN consider genetic counseling?
Genetic counseling may be helpful when several relatives have similar progressive weakness or when symptoms began unusually early in life. A neurologist or genetic counselor can review the family history and testing to check whether another inherited nerve condition should be considered.
Does a positive anti-GM1 antibody test prove that someone has MMN?
A positive anti-GM1 antibody test can support an MMN diagnosis, but it does not prove it by itself. Some people with MMN have a negative result, so doctors interpret the test together with symptoms, examination findings, and electrodiagnostic studies.

Get notified when new evidence is published on Multifocal motor neuropathy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (7)
  1. 1

    Multifocal Motor Neuropathy: A Narrative Review.

    Claytor B, Polston D, Li Y

    Muscle & nerve 2025; (71(4)):512-534 doi:10.1002/mus.28349.

    PMID: 39936246
  2. 2

    Autoantibody pathogenicity in a multifocal motor neuropathy induced pluripotent stem cell-derived model.

    Harschnitz O, van den Berg LH, Johansen LE, et al.

    Annals of neurology 2016; (80(1)):71-88 doi:10.1002/ana.24680.

    PMID: 27130524
  3. 3

    IgM Anti-Ganglioside Binding and Complement Activation in an iPSC-Derived Motor Neuron Model for Multifocal Motor Neuropathy.

    Krijgsman D, Dijkxhoorn K, de Zeeuw E, et al.

    Neurology(R) neuroimmunology & neuroinflammation 2026; (13(1)):e200482 doi:10.1212/NXI.0000000000200482.

    PMID: 41223338
  4. 4

    High-resolution mapping identifies HLA class II associations with multifocal motor neuropathy.

    Bos JW, Otten HG, Herraets IJT, et al.

    Neurobiology of aging 2021; (101()):79-84 doi:10.1016/j.neurobiolaging.2021.01.014.

    PMID: 33582569
  5. 5

    A 21-bp deletion in the complement regulator CD55 promotor region is associated with multifocal motor neuropathy and its disease course.

    Bos JW, Groen EJN, Otten HG, et al.

    Journal of the peripheral nervous system : JPNS 2024; (29(2)):193-201 doi:10.1111/jns.12620.

    PMID: 38528725
  6. 6

    A Practical Guide to Identify Patients With Multifocal Motor Neuropathy, a Treatable Immune-Mediated Neuropathy.

    Allen JA, Clarke AE, Harbo T

    Mayo Clinic proceedings. Innovations, quality & outcomes 2024; (8(1)):74-81 doi:10.1016/j.mayocpiqo.2023.12.002.

    PMID: 38283096
  7. 7

    Differentiating lower motor neuron syndromes.

    Garg N, Park SB, Vucic S, et al.

    Journal of neurology, neurosurgery, and psychiatry 2017; (88(6)):474-483 doi:10.1136/jnnp-2016-313526.

    PMID: 28003344

This page is for informational purposes only and does not constitute medical advice about MMN or your family's risk. A neurologist or genetic counselor can interpret your symptoms, family history, and test results.